FDA Shortage List
Official FDA registry of drugs in supply shortage. During active shortage, compounding of copies is permitted under specific conditions. Semaglutide and tirzepatide were both resolved off this list in October 2024.
Official FDA registry of drugs in supply shortage. During active shortage, compounding of copies is permitted under specific conditions. Semaglutide and tirzepatide were both resolved off this list in October 2024.